Aptevo Therapeutics (AP82.F) Q4 2025 Earnings

6NovConfirmed
Q4 2025
-34.75
-34.03
-33.3
-32.57

Details

Expected EPS
-32.571019799999995
Actual EPS
-34.7528106
Surprise EPS
-2.18
Surprise Percent
+6.7%

Description

Aptevo Therapeutics (AP82.F) has reported earnings of -34.7528106 per share for Q4 2025.

0 Comments

Share your thoughts